Source: Eur Respir J 2003; 21: 37-42
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
McShane D., Davies J.C., Davies M.G., Bush A., Geddes D.M., Alton E.W.F.W.. Airway surface pH in subjects with cystic fibrosis. Eur Respir J 2003; 21: 37-42

Member's Comments

No comment yet.

Related content which might interest you: Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Channelopathies in bronchiectasis Source: Eur Respir Mon 2011; 52: 150-162 Year: 2011 Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 450s Year: 2007 Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma Source: Eur Respir J 2011; 37: 342 Year: 2011 RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 Airway inflammation in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 14-31 Year: 2014 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 Airway clearance techniques in cystic fibrosis Source: Eur Respir J 2006; 27: 1082-1083 Year: 2006 Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH Source: Eur Respir J, 52 (6) 1801297; 10.1183/13993003.01297-2018 Year: 2018 Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 The assesment of aerosol solution lung deposition in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 584s Year: 2004 Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function Source: Eur Respir J 2011; 37: 1076-1082 Year: 2011 Measurement of airways obstruction among preschoolers with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 The relationship between airway bacterial load and airways inflammation in stable non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Small airways disease in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=21 Year: 2006 The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020